Company / SG&A Expense
Aveanna Healthcare Holdings, Inc. SG&A Expense History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$352.8M
FY2024
5-year range
$240.9M / $361.0M
FY2020-FY2024
Trend
-2.3%
vs FY2023
Sector context
#80 of 152
Health Care
What the data says
At $353M, Aveanna Healthcare Holdings, Inc.'s sg&a expense ranks #73 of 152 in the Health Care sector.
Based on SEC 10-K filings.
$353M in FY2024 with a 5-year CAGR of +9.1%.
Remained stable around $353M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
#73 of 152 in Health CareTop 47% of 152This company $352.8M Sector average $182.7B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2024, sg&a expense decreased 2.3% year-over-year.
- Ranks #80 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $352.8M | -2.3% |
| FY2023 | $361.0M | +1.0% |
| FY2022 | $357.2M | +20.1% |
| FY2021 | $297.4M | +23.4% |
| FY2020 | $240.9M | +5.8% |
| FY2019 | $227.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026